Assessment of Safety and Biodistribution of a miniMECP2 AAV9 Vector for Gene-replacement Therapy of Rett Syndrome in Non-human Primates (NHPs)

被引：0
|
作者：
Prasad, S. [1 ]
Flora, G. [1 ]
Newman, M. [1 ]
Gray, S. J. [2 ]
Sinnett, S. [2 ]
Sadhu, C. [1 ]
机构：
[1] Taysha Gene Therapies R&D, Dept Res & Dev, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA
来源：
HUMAN GENE THERAPY | 2022年 / 33卷 / 23-24期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P238
引用
收藏
页码：A89 / A90
页数：2
相关论文
共 34 条
  • [31] The Safety and Efficacy of Pre-Treatment with Imlifidase Prior to Adeno Associated Virus (AAV)-Based Gene Therapy in Non-Human Primates with Pre-Existing Anti-AAVrh74 Antibodies
    Potter, Rachael
    Khan, Sohrab
    Snedeker, John
    Adegboye, Kaitlin
    Haile, Alex
    Sayanjali, Behnam
    Pukos, Nicole
    Cochran, Kyle
    Ahner, Jen
    Su, Ting
    Uzcategui, Nathalie
    Stenberg, Yvonne
    Freiburghaus, Catja
    Winstedt, Lena
    Rodino-Klapac, Louise
    MOLECULAR THERAPY, 2023, 31 (04) : 40 - 40
  • [32] Intravenous AAV5 Gene Therapy with Human CYP21A1 Corrects Phenotypic Deficiencies of the 21-Hydroxylase Kockout Mouse Model and Demonstrates Durability and Safety in Non-Human Primates and Mice
    Eclov, Rachel
    Le Fur, Sophie
    Scott, David
    Dos Santos, Christine
    Belot, Marie-Pierre
    Kapadia, Mayank
    Lewis, Terra
    Rouse, Jeremy
    Romero, Kirsten
    Stella, Alexandre
    Goumeaux, Cyndie
    Liere, Philippe
    Hantraye, Philippe
    Amalric, Francois
    Beard, Clayton
    Bougneres, Pierre
    MOLECULAR THERAPY, 2021, 29 (04) : 122 - 123
  • [33] A Multi-Mechanistic Anti-Angiogenic AAV Gene Therapy Product Candidate, 4D-150, for the Treatment of Wet Age-Related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME): Intravitreal Biodistribution, Transgene Expression, Safety and Efficacy in Non-Human Primates
    Francis, Peter J.
    Francis, Peter J.
    Burns, Christian
    Szymanski, Paul
    Leong, Meredith
    Mohaghegh, Nima
    Schmitt, Christopher
    Klein, Austin
    Croze, Roxanne H.
    Calton, Melissa A.
    Khoday, Devi
    Kotterman, Melissa
    Barglow, Katherine
    Schaffer, David
    Kirn, David
    MOLECULAR THERAPY, 2021, 29 (04) : 31 - 32
  • [34] Relevance of NHP safety studies for ocular delivery of AAV-based gene therapy in humans: Example of GS010 (rAAV2/2-ND4) local tolerability, shedding and immunogenicity for the treatment of Leber Hereditary Optic Neuropathy (LHON), after intravitreal (IVT) injection in non-human primates (NHP) and in LHON patients
    Thomasson, Nitza
    Galy, Anne
    Fitoussi, Serge
    Meunier, Sandrine
    Uretsky, Scott
    Combal, Jean-Philippe
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
1234